Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Anemic Patients with Cervical Cancer Receiving Chemoradiation
NCT00017004Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Aug 2001
- Primary completion
- May 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in Cervical Cancer (CC), sponsored by GOG Foundation. Started Aug 2001; status: completed.
02
Drugs
epoetin alfa
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00017004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017004.